Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Details for Australian Patent Application No. 2011213703 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Chu, Zhi-Liang; Leonard, James N.; AlShamma, Hussien A.; Jones, Robert M.

Agent FB Rice

Pub. Number AU-A-2011213703

Parent 2006205164

Filing date 16 August 2011

Wipo publication date 8 September 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/401 (2006.01) - Proline

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

Event Publications

1 September 2011 Complete Application Filed

8 September 2011 Application Open to Public Inspection

  Published as AU-A-2011213703

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011213704-Application-layer combining of multimedia streams delivered over multiple radio access networks and delivery modes

2011213702-Surface Augmentation System and Method